Pillstats
Rx only · Injection, Solution · Intramuscular

Furosemide

Furosemide

12 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US25 NDCs
12 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers12 labelers
Packages53
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 19 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.109$0.219$0.328$0.438Jul 2025Feb 2026Jun 2026
$0.371
Latest avg · Jun 17, 2026
+66%
Since Jul 23, 2025
12
Active US suppliers
32%
Top-2 supplier share*

Who makes it12 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
HF Acquisition Co LLC, DBA HealthFirstunknown11SUPPLYING
Sagent Pharmaceuticalsunknown6SUPPLYING
Fresenius Kabi USA, LLCunknown6SUPPLYING
Hospira, Inc.unknown6SUPPLYING
Gland Pharma Limitedunknown6SUPPLYING
Meitheal Pharmaceuticals Inc.unknown5SUPPLYING
Cardinal Health 107, LLCunknown4SUPPLYING
Avenacy, LLCunknown3SUPPLYING
Eugia US LLCunknown3SUPPLYING
Henry Schein Inc.unknown1SUPPLYING
Medical Purchasing Solutions, LLCunknown1SUPPLYING
Phlow Corporationunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.